Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Charles Gross

1934 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Asset Sales
  • M&A
  • News

China Yuchai Entered Agreementt For Sale Of Suzhou Remanufacturing Unit To Beijing Liandong For RMB 179.94M

By Charles Gross
December 31, 10:55 AM
China Yuchai International Limited (NYSE:CYD) ("China Yuchai" or the "Company), one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery

CYD

Read More
1 minute read
  • News

Fresenius Majority-Owned Group Mabxience Has Licensing Agreement With Intas Pharmaceuticals for Autoimmune Disease Drug Etanercept

By Charles Gross
December 20, 6:02 AM
 Intas Pharmaceuticals Ltd., a leading multinational pharmaceutical company, has announced today a strategic exclusive licensing agreement with mAbxience (a Fresenius Kabi majority-owned group with partial

FMS

Read More
1 minute read
  • Buybacks
  • News
  • Penny Stocks
  • Small Cap

GDEV Announced Commencement Of Self Tender Offer To Purchase A Minimum Of 15M To 20M Ordinary Shares At $2.00 Per Ordinary Share

By Charles Gross
December 19, 7:09 AM
GDEV Inc.

GDEV

Read More
1 minute read
  • Asset Sales
  • M&A
  • News

Illumina To Divest Grail Through A Third-party Sale Or Capital Markets Transaction, Consistent With The European Commission’s Divestiture Order

By Charles Gross
December 17, 3:39 PM
Today, Illumina, Inc. (NASDAQ:ILMN) announced that the company will divest GRAIL. The divestiture will be executed through a third-party sale or capital markets transaction, consistent with the European Commission's

ILMN

Read More
1 minute read
  • FDA
  • News

FDA Approved Merck’s WELIREG For The Treatment Of Patients With Advanced Renal Cell Carcinoma (RCC) Following A PD-1 or PD-L1 Inhibitor And A VEGF-TKI

By Charles Gross
December 14, 8:34 PM
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved WELIREG, an oral hypoxia-inducible factor-2 alpha (HIF-2α)

MRK

Read More
1 minute read
  • News
  • Offerings

Eos Energy Prices 34,482,759 Shares Plus Accompanying Warrants At $1.45/Unit

By Charles Gross
December 14, 8:32 PM
- Eos Energy Enterprises, Inc. (NASDAQ:EOSE) ("Eos" or the “Company”), a leading provider of safe, scalable, efficient, and sustainable zinc-based long duration energy storage

EOSE

Read More
1 minute read
  • News
  • Tech

Apple Expands Self Service Repair And Introduces New Diagnostics Process

By Charles Gross
December 13, 8:05 AM
Apple is expanding Self Service Repair, and launching a new diagnostic tool that gives users more transparency and autonomy to troubleshoot issues. Self Service Repair is now available for the iPhone 15 line-up and

AAPL

Read More
1 minute read
  • Legal
  • News

5E Advanced Materials To Hold Stockholder Call December 19, 2023; Will Discuss Contingencies, Including Potential Pre-packaged Chapter 11 Bankruptcy

By Charles Gross
December 12, 6:09 PM
 5E Advanced Materials, Inc. (NASDAQ:FEAM) (ASX: 5EA) ("5E" or the "Company"), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas

FEAM

Read More
1 minute read
  • Events
  • News

TScan Therapeutics on Saturday Presented Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition

By Charles Gross
December 11, 8:39 AM
TScan Therapeutics, Inc. (NASDAQ:TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today

TCRX

Read More
2 minute read
  • News

Fiscalnote Holdings Entered Strategic Commercial Partnership With EGT-East

By Charles Gross
December 11, 7:59 AM
On December 8, 2023 (the "Issuance Date"), FiscalNote Holdings, Inc. (the "Company") entered into a strategic commercial partnership with EGT-East, LLC, an affiliate of Era Global Technologies, LLC, a

NOTE

Posts pagination

Previous 1 … 6 7 8 … 194 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service